Management of patients with herpes simplex virus eye disease having cataract surgery in the United Kingdom
- 1 August 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cataract & Refractive Surgery
- Vol. 39 (8), 1254-1259
- https://doi.org/10.1016/j.jcrs.2013.06.005
Abstract
To standardize the management of patients with herpetic eye disease scheduled for cataract surgery, a questionnaire was sent to each fellow of the Royal College of Ophthalmologists registered as a consultant with a subspecialty interest in cornea. Most respondents agreed that disease stability was required before cataract surgery was offered; 62.3% would operate on patients in whom the disease had been quiescent for 3 to 6 months. The decision to prescribe prophylactic antivirals divided the respondents, with 58.8% in favor of starting antiviral treatment. Most respondents (72.46%) did not start topical antiviral treatment. In regard to changing topical steroid use postoperatively, 80.9% would not change their routine regimen. Oral acyclovir was the first line of treatment for 92.5%. The conclusions were that a significant period of inactivity should be considered before cataract surgery is performed in patients with herpes simplex virus eye disease. Oral antiviral prophylaxis is common clinical practice, but no change in routine postoperative steroid use is needed. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.Keywords
This publication has 11 references indexed in Scilit:
- Unusual clinical presentations of new‐onset herpetic eye disease after ocular surgeryActa Ophthalmologica, 2010
- Cataract and Refractive Surgery in Herpetic Eye DiseaseInternational Ophthalmology Clinics, 2010
- Laser in situ keratomileusis in patients with a history of ocular herpesJournal of Cataract & Refractive Surgery, 2007
- Effect of Prophylactic Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex KeratitisCornea, 2007
- The value of surveys for cataract and refractive surgeryJournal of Cataract & Refractive Surgery, 2003
- Restricted T Cell Receptor β‐Chain Variable Region Protein Use by Cornea‐Derived CD4+and CD8+Herpes Simplex Virus–Specific T Cells in Patients with Herpetic Stromal KeratitisThe Journal of Infectious Diseases, 2003
- Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2001
- Herpetic Eye Disease StudyOphthalmology, 1994
- Epidemiology of Ocular Herpes SimplexAmerican Journal of Ophthalmology, 1989
- Effect of Ketorolac on Herpes Simplex Virus Type One Ocular Infection in RabbitsJournal of Ocular Pharmacology and Therapeutics, 1988